IDXX

IDEXX Laboratories
D

IDXX

427.10
USD
7.85
(1.87%)
Market Closed
Volume
0
EPS
11
Div Yield
-
P/E
41
Market Cap
34,972,939,994
Related Instruments
    NEOUSD
    NEOUSD
    -0.042
    (-0.29%)
    14.476 USD
    A
    AIZ
    -1.930
    (-0.91%)
    209.720 USD
    E
    EBS
    0.315
    (3.19%)
    10.200 USD
    H
    HOLX
    0.630
    (0.90%)
    70.360 USD
    HUM
    HUM
    2.04
    (0.72%)
    284.71 USD
    I
    IDA
    1.510
    (1.37%)
    111.820 USD
    IQV
    IQV
    8.640
    (4.38%)
    206.000 USD
    N
    NEO
    -0.015
    (-0.11%)
    14.185 USD
    STE
    STE
    7.390
    (3.53%)
    216.980 USD
    WST
    WST
    7.94
    (2.36%)
    344.56 USD
    ZTS
    ZTS
    1.640
    (0.99%)
    167.500 USD
    More
News

Title: IDEXX Laboratories

Sector: Healthcare
Industry: Diagnostics & Research
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ inthe office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.